Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT 2021

TCT 602: Percutaneous Atrial Septal Defect Closure in an Adult With Ebstein Anomaly as a Palliative Therapy for Recurrent Stroke

Presenter: Alex Cubberley

November 05, 2021

Presentation TCT 2021

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Presenter: Zachi Berger

November 04, 2021

Presentation TCT 2021

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Presenter: Jens Erik Nielsen-Kudsk

November 04, 2021

Presentation ESC 2021

Implantable Loop Recorder to Detect Atrial Fibrillation and Prevent Stroke (The LOOP Study): A Randomised Controlled Trial

Presenter: Jesper Hastrup Svendsen

August 31, 2021

Presentation TVT 2021

PFO Closure in Non-Stroke Patients

Presenter: Brian Whisenant

July 22, 2021

Presentation TVT 2021

PFO Closure for Stroke: When Should We Consider Patients Over 60 Years of Age?

Presenter: Megan Coylewright

July 22, 2021

Presentation TVT 2021

When Both Silent AF and PFO Are Discovered During a Cryptogenic Stroke Work-up, the Optimal Therapy to Prevent Stroke Recurrence Is…

Presenter: Mark Reisman

July 22, 2021

Presentation TVT 2021

Next Generation Stroke Reduction

Presenter: Wayne Batchelor

July 21, 2021

Presentation TVT 2021

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Presenter: George Dangas

July 21, 2021

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

Presentation TVT 2021

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Presenter: Amar Krishnaswamy

July 21, 2021

Advertisement

TCT 602: Percutaneous Atrial Septal Defect Closure in an Adult With Ebstein Anomaly as a Palliative Therapy for Recurrent Stroke

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Implantable Loop Recorder to Detect Atrial Fibrillation and Prevent Stroke (The LOOP Study): A Randomised Controlled Trial

PFO Closure in Non-Stroke Patients

PFO Closure for Stroke: When Should We Consider Patients Over 60 Years of Age?

When Both Silent AF and PFO Are Discovered During a Cryptogenic Stroke Work-up, the Optimal Therapy to Prevent Stroke Recurrence Is…

Next Generation Stroke Reduction

Does Medical Therapy Make a Difference: Anti-Platelet and Anti-Thrombotic Therapy After TAVR

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Does LAA Occlusion Make Sense in TAVR AF Patients: Updates From WATCH TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content